Century Therapeutics annual r&d spending
2020
2021
2022
2023
2024
2025
Century Therapeutics R&D Spending Growth & History (IPSC)
Century Therapeutics's r&d spending was $95.7M for fiscal 2025.
View full Century Therapeutics company overviewCentury Therapeutics annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $95.7M | −$11.6M | −10.80% |
| 2024 | 2024-12-31 | $107.2M | $14.5M | +15.68% |
| 2023 | 2023-12-31 | $92.7M | −$4.5M | −4.59% |
| 2022 | 2022-12-31 | $97.2M | $21.5M | +28.45% |
| 2021 | 2021-12-31 | $75.6M | $36.0M | +90.64% |
| 2020 | 2020-12-31 | $39.7M | — | — |
Century Therapeutics quarterly r&d spending
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $19.6M | −$7.3M | −27.04% |
| Q1 2026 | 2026-03-31 | $17.1M | −$9.5M | −35.65% |
| Q4 2025 | 2025-12-31 | $19.7M | −$9.7M | −32.93% |
| Q3 2025 | 2025-09-30 | $22.5M | −$4.7M | −17.27% |
| Q2 2025 | 2025-06-30 | $26.9M | −$361,000 | −1.33% |
| Q1 2025 | 2025-03-31 | $26.6M | $3.2M | +13.49% |
| Q4 2024 | 2024-12-31 | $29.4M | $7.1M | +31.75% |
| Q3 2024 | 2024-09-30 | $27.2M | $4.4M | +19.48% |
| Q2 2024 | 2024-06-30 | $27.2M | $4.5M | +19.77% |
| Q1 2024 | 2024-03-31 | $23.4M | −$1.5M | −5.94% |
| Q4 2023 | 2023-12-31 | $22.3M | −$3.3M | −12.86% |
| Q3 2023 | 2023-09-30 | $22.8M | −$3.1M | −12.01% |
| Q2 2023 | 2023-06-30 | $22.7M | −$1.8M | −7.21% |
| Q1 2023 | 2023-03-31 | $24.9M | $3.7M | +17.47% |
| Q4 2022 | 2022-12-31 | $25.6M | $3.8M | +17.38% |
| Q3 2022 | 2022-09-30 | $25.9M | $6.4M | +32.50% |
| Q2 2022 | 2022-06-30 | $24.5M | $5.6M | +29.37% |
| Q1 2022 | 2022-03-31 | $21.2M | $5.8M | +37.87% |
| Q4 2021 | 2021-12-31 | $21.8M | — | — |
| Q3 2021 | 2021-09-30 | $19.5M | $8.7M | +80.77% |
| Q2 2021 | 2021-06-30 | $18.9M | $10.4M | +123.16% |
| Q1 2021 | 2021-03-31 | $15.4M | — | — |
| Q3 2020 | 2020-09-30 | $10.8M | — | — |
| Q2 2020 | 2020-06-30 | $8.5M | — | — |
Century Therapeutics r&d spending trends
Over the last five fiscal years, Century Therapeutics's r&d spending increased from $39.7M to $95.7M, a change of $56.0M. The latest reported quarter, Q2 2026, shows $19.6M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Century Therapeutics source filings ↗